Induced pluripotent stem cells (iPSCs) can be generated from various differentiated cell types by the expression of a set of defined transcription factors.
Abstract
Induced pluripotent stem cells (iPSCs) can be generated from various differentiated cell types by the expression of a set of defined transcription factors.
So far, iPSCs have been generated from primary cells but it is unclear if human cancer cell lines can be reprogrammed. Here we describe the generation and characterization of iPS cells derived from human chronic myeloid leukemia (CML) cells. We show that despite the presence of oncogenic mutations these cells acquired pluripotency by the expression of four transcription factors and underwent differentiation into cell types derived of all three germ layers during teratoma formation. Interestingly, although the parental cell line was strictly dependent on continuous signaling of the BCR-ABL oncogene -also termed oncogene addiction-reprogrammed cells lost this dependency and became resistant to the BCR-ABL inhibitor imatinib. This finding indicates that the therapeutic agent imatinib targets cells in a specific epigenetic differentiated cell state and this may contribute to its inability to fully eradicate disease in CML patients.
Introduction
Tumors develop in the context of a particular developmental state by acquiring mutations in oncogenes and tumor suppressor genes. Oncogenic mutations are often observed in a tissue-or cell type-specific manner . However, until now this has not been achieved for human tumor cells.
Methods
Detailed methods are provided in supplemental methods online. All animal experiments were approved by the committee of animal care from Whitehead Institute.
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Results and Discussion
To address whether human cancer cells can be reprogrammed into iPS cells, we or KLF4 had a less dramatic phenotype and adherent colonies formed. However, these colonies maintained CD43 marker expression and did not exhibit ES cell morphology ( Figure S3 ) suggesting that none of the four factors is dispensable.
In the chronic phase of CML the BCR-ABL mutation drives cell expansion but cells retain the capacity to undergo differentiation 11 . Subsequently, secondary lesions lead to blast crisis, which is characterized by the inability to undergo 
